Sector consensus Merck & Co., Inc.

Equities

Market Closed - Nyse Other stock markets 04:00:02 2025-01-10 pm EST			5-day change	1st Jan Change
99.25 ^USD	-0.60%		+0.11%	-0.23%

Jan. 10	Atropos Health, Inc. Collaborates with Merck for Rapid Evidence Generation to Accelerate Innovation for Life-Saving Treatments	CI
Jan. 09	IO Biotech Completes Enrollment in Phase 2 Trial of Cancer Vaccine to Treat Resectable Melanoma	MT

Sector:

Location:

X axis:

Main competitors

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Average Target P.	Ecart obj. / dr	Nbr of analysts
MERCK & CO., INC.	127.05	+28.01%	25
ELI LILLY AND COMPANY	984.05	+23.02%	27
NOVO NORDISK A/S	842.55	+33.25%	22
JOHNSON & JOHNSON	171.61	+20.80%	22
ABBVIE INC.	202.33	+15.50%	28
ROCHE HOLDING AG	303.25	+13.49%	18
ASTRAZENECA PLC	175.24	+30.81%	19
NOVARTIS AG	113.75	+14.58%	19
PFIZER, INC.	31.78	+18.92%	23
AMGEN INC.	317.24	+20.98%	26
SANOFI	113.80	+19.03%	21
BRISTOL-MYERS SQUIBB COMPANY	61.01	+9.27%	21
GILEAD SCIENCES, INC.	99.96	+11.21%	26
CHUGAI PHARMACEUTICAL CO., LTD	7,416.67	+10.09%	15
GSK PLC	18.17	+34.63%	18
DAIICHI SANKYO CO., LTD.	6,333.33	+53.35%	18
TAKEDA PHARMACEUTICAL COMPANY LIMITED	4,759.71	+15.50%	17
HALEON PLC	3.993	+7.42%	17
JIANGSU HENGRUI MEDICINE CO., LTD.	59.81	+40.17%	17
Average	1,165.01	+22.11%	21
Weighted average by Cap.	676.33	+22.07%	23